Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 2
1998 1
2001 1
2002 2
2005 1
2006 1
2007 4
2008 4
2009 4
2010 2
2011 5
2012 4
2013 3
2014 5
2015 8
2016 16
2017 10
2018 8
2019 3
2020 5
2021 14
2022 20
2023 17
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
Wu YL, Dziadziuszko R, Ahn JS, Barlesi F, Nishio M, Lee DH, Lee JS, Zhong W, Horinouchi H, Mao W, Hochmair M, de Marinis F, Migliorino MR, Bondarenko I, Lu S, Wang Q, Ochi Lohmann T, Xu T, Cardona A, Ruf T, Noe J, Solomon BJ; ALINA Investigators. Wu YL, et al. N Engl J Med. 2024 Apr 11;390(14):1265-1276. doi: 10.1056/NEJMoa2310532. N Engl J Med. 2024. PMID: 38598794 Clinical Trial.
Response to the letter to the editor.
Guner R, Hasanoglu I, Kayaaslan B, Aypak A, Akinci E, Bodur H, Eser F, Kaya Kalem A, Kucuksahin O, Ates I, Bastug A, Tezer Tekce Y, Bilgic Z, Gursoy FM, Akca HN, Izdes S, Erdem D, Asfuroglu E, Hezer H, Kilic H, Civak M, Aydogan S, Buzgan T. Guner R, et al. Among authors: erdem d. J Infect Public Health. 2022 Jan;15(1):65-67. doi: 10.1016/j.jiph.2021.12.007. Epub 2021 Dec 11. J Infect Public Health. 2022. PMID: 34915424 Free PMC article. No abstract available.
Adverse outcomes and maternal complications in pregnant women with severe-critical COVID-19: a tertiary center experience.
Sinaci S, Tanacan A, Besimoglu B, Menekse Beser D, Uyan Hendem D, Tugrul Ersak D, Atalay A, Kaya E, Ozden Tokalioglu E, Cankar Dal H, Ocal DF, Erdem D, Izdes S, Moraloglu Tekin O, Ates İ, Turan S, Sahin D. Sinaci S, et al. Among authors: erdem d. J Perinat Med. 2023 May 3;51(7):874-885. doi: 10.1515/jpm-2022-0564. Print 2023 Sep 26. J Perinat Med. 2023. PMID: 37134274
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.
Bilici A, Koca S, Karaagac M, Aydin SG, Eraslan E, Kaplan MA, Ocak B, Goksu SS, Paydas S, Akgul F, Derin S, Ergun Y, Yekeduz E, Erol C, Ozyukseler DT, Demiray AG, Karaca M, Guc ZG, Menekse S, Cinkir HY, Gumusay O, Sakin A, Ozkul O, Demir H, Erdem D, Besiroglu M, Unal OU, Acar R, Koral L, Sahin S, Sakalar T, Bahceci A, Ozveren A, Gunaydin UM, Seker MM, Sunar V, Dal P, Artac M, Turhal S. Bilici A, et al. Among authors: erdem d. J Cancer Res Clin Oncol. 2023 Sep;149(11):8243-8253. doi: 10.1007/s00432-023-04766-3. Epub 2023 Apr 17. J Cancer Res Clin Oncol. 2023. PMID: 37067546
Secondary bacterial infections of the respiratory tract in COVID-19 patients.
Mumcuoğlu İ, Çağlar H, Erdem D, Aypak A, Gün P, Kurşun Ş, Çakır EY, Aydoğan S, Kırca F, Dinç B. Mumcuoğlu İ, et al. Among authors: erdem d. J Infect Dev Ctries. 2022 Jul 28;16(7):1131-1137. doi: 10.3855/jidc.16724. J Infect Dev Ctries. 2022. PMID: 35905017 Free article.
Evaluation of Patients with COVID-19 Followed Up in Intensive Care Units in the Second Year of the Pandemic: A Multicenter Point Prevalence Study.
Güngör S, Ediboğlu Ö, Yazıcıoğlu Moçin Ö, Adıgüzel N, Tuncay E, Ekiz İşcanlı İG, Er B, Karakurt Z, Turan S, Kosovalı BD, Mutlu NM, Kayar D, Gökbulut Bektaş Ş, Uysal E, Seğmen F, Alp G, Erdem D, Has Selmi N, Güven P, Özçelik Z, Ocakcıoğlu M, Yazıcı Özgür C, Yılmaz R, Bilgi Özel D, Cebeci H, Güler B, Cansever C, Çakırca M, İnceöz H, Solmaz İ, Özkan Sipahioğlu F, Aydın EM, Dayanır H, Öner SF, Karatepe U, Özen S, Boran M, Ergül DF, Kasapoğlu US, Delen LA, Toy E, Altun K, Albayrak T, Yanal H, Zaim G, Yarar V, Kılınç G, Deniz M, Özdemir E, Soylu VG, Yılmaz A, Saygılı SM, Öztürk EK, Ergan B, Eyüpoğlu S, Şahin Y, Yüksel B, Bulut A, Sarıtaş A, Yeniay H, Genç M, Kargın F, Özcan O, Karakoç E, Karaca Ü, Sözütek D, Sarı S, Şenoğlu N, Aygün H, Yiğit AC, Kavruk N, Uzan ÇA, Bıçakcıoğlu M, Solak S, Kutbay Özçelik H, Uluç K, Yıldırım İ, Arar MC, Demirel İ, Küver SU, Özgür ES, Aydın K, Erdal Dönmez G, Aygencel G, Esmaoğlu A, Sebil Aydın B, Tokur ME, Korkmaz Ekren P, Aydemir Y, Çakır Güney B, Erdil ÖY, Tünay A, Bahadır T, Uçkun S, Kocaoğlu N, Pınar HU, Kutluer Karaca N, Gültekin H, Ayvat P, Belin Özer A, Eroğlu A, Kuyrukluyıldız U, Baytar Ç, Ayoğlu H, Mızrakçı S, Metin H, Zanbak Mutlu ÖP, Yılm… See abstract for full author list ➔ Güngör S, et al. Among authors: erdem d. Thorac Res Pract. 2023 Nov 23. doi: 10.5152/ThoracResPract.2023.23024. Online ahead of print. Thorac Res Pract. 2023. PMID: 37994835
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study.
Bilici A, Olmez OF, Kaplan MA, Oksuzoglu B, Sezer A, Karadurmus N, Cubukcu E, Sendur MAN, Aksoy S, Erdem D, Basaran G, Cakar B, Shbair ATM, Arslan C, Sumbul AT, Sezgin Goksu S, Karadag I, Cicin I, Gumus M, Selcukbiricik F, Harputluoglu H, Demirci U. Bilici A, et al. Among authors: erdem d. Acta Oncol. 2023 Apr;62(4):381-390. doi: 10.1080/0284186X.2023.2202330. Epub 2023 Apr 21. Acta Oncol. 2023. PMID: 37083566
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy.
Karacin C, Oksuzoglu B, Demirci A, Keskinkılıç M, Baytemür NK, Yılmaz F, Selvi O, Erdem D, Avşar E, Paksoy N, Demir N, Göksu SS, Türker S, Bayram E, Çelebi A, Yılmaz H, Kuzu ÖF, Kahraman S, Gökmen İ, Sakin A, Alkan A, Nayır E, Uğraklı M, Acar Ö, Ertürk İ, Demir H, Aslan F, Sönmez Ö, Korkmaz T, Celayir ÖM, Karadağ İ, Kayıkçıoğlu E, Şakalar T, Öktem İN, Eren T, Erul E, Mocan EE, Kalkan Z, Yıldırım N, Ergün Y, Akagündüz B, Karakaya S, Kut E, Teker F, Demirel BÇ, Karaboyun K, Almuradova E, Ünal OÜ, Oyman A, Işık D, Okutur K, Öztosun B, Gülbağcı BB, Kalender ME, Şahin E, Seyyar M, Özdemir Ö, Selçukbiricik F, Kanıtez M, Dede İ, Gümüş M, Gökmen E, Yaren A, Menekşe S, Ebinç S, Aksoy S, İmamoğlu Gİ, Altınbaş M, Çetin B, Uluç BO, Er Ö, Karadurmuş N, Erdoğan AP, Artaç M, Tanrıverdi Ö, Çiçin İ, Şendur MAN, Oktay E, Bayoğlu İV, Paydaş S, Aydıner A, Salim DK, Geredeli Ç, Yavuzşen T, Doğan M, Hacıbekiroğlu İ. Karacin C, et al. Among authors: erdem d. BMC Cancer. 2023 Feb 10;23(1):136. doi: 10.1186/s12885-023-10609-8. BMC Cancer. 2023. PMID: 36765293 Free PMC article.
A single center experience of intravenous immunoglobulin treatment in Covid-19.
Omma A, Erden A, Armağan B, Güven SC, Karakaş Ö, Şahiner ES, Erdem D, İzdeş S, Ateş İ, Küçükşahin O. Omma A, et al. Among authors: erdem d. Int Immunopharmacol. 2021 Sep;98:107891. doi: 10.1016/j.intimp.2021.107891. Epub 2021 Jun 14. Int Immunopharmacol. 2021. PMID: 34153671 Free PMC article.
Polymer nanocomposite patterning by dip-pen nanolithography.
Kandemir AC, Erdem D, Ma H, Reiser A, Spolenak R. Kandemir AC, et al. Among authors: erdem d. Nanotechnology. 2016 Apr 1;27(13):135303. doi: 10.1088/0957-4484/27/13/135303. Epub 2016 Feb 24. Nanotechnology. 2016. PMID: 26909592
115 results